As Global Business Development Officer, Marcello Agosti is responsible for Takeda’s Business Development activities, including M&A and Corporate Development.
Mr. Agosti has been leading the potential Shire acquisition since its inception. Additionally, he has led several strategic acquisitions for Takeda, including ARIAD Pharmaceuticals, transforming Takeda’s global Oncology portfolio and TiGenix, and strengthening the company’s GI leadership position.
Mr. Agosti has also been leading Takeda’s Global Commercial organization since 2015, which included the successful launch of Takeda’s first global brand, Entyvio, now approved in more than 60 countries.
He has also held a number of leadership positions in Europe as Country Manager in France and in Italy and as Area Head of Southern and Eastern Europe.
Prior to joining Takeda, Mr. Agosti worked in business development at Novartis in the U.K. and Switzerland.
Before joining the industry, he was a consultant at McKinsey & Co.
An Italian national, Mr. Agosti holds a degree in Business Administration from Bocconi University, Milan, and an MBA from the University of Oxford.